Nano-KGIC™ COVID-19 IgM/IgG KIT


Nano-KGIC™ COVID-19 IgM/IgG KIT

Detention of COVID-19 IgM antibodies tends to indicate a recent exposure to covid-19, whereas detection of COVID-19 IgG antibodies indicates a later stage of infection.

Thus, this combined antibody test could also provide information on the stage of infection.

 
  Features

  • Rapid Testing for nCoV antibodies within 15 minutes
  • Detect and differentiate IgM/IgG antibody specific to SARA-CoV-2
  • Require small sample volume(10uL of whole blood, serum, or plasma)
  • No Additonal Equipment required
  • As a supplementary detection indicator for suspected cases with negative nucleic acid detection, or in conjunction with PCR in diagnosis of suspected cases

Features  

Clinical Performance

SARS-CV-2 Nano-KGIC™ COVID-19 IgM/IgGKit
Clinical sensitivity
(IgM and/orIgG)
97.0% (95% CI: 95.3 –98.7%)
Clinical specificity 100% (95% CI: 98.3%–100%)

Out of 33 SARS-CoV-2 positive samples confirmed by the RT-PCR, the Nano-KGIC™ COVID-19IgM/IgG detected 32 positive samples (97%)

Out of 30 SARS-CoV-2 negative samples confirmed by the RT-PCR, The-KGIC™ COVID-19 IgM/IgG showed the specificity of 100%

Order Information

Cat.No. SRK-001
Package Unit 25 tests/kit
Kit Component Test cassette, Assay buffer vial, Instructions for use
Storage Temperature 2~30 ℃(36-86℉)
Specimen Whole blood/serum/plasma